Tushar Ranchod, MD
Retina Specialist · Walnut Creek, CANPI 1316003304
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for retina specialist clinicians in CA, where the typical reported total is $3,667.
Across 62 payments — averaging $39.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ANI Pharmaceuticals, Inc.$578
- Genentech USA, Inc.$570
- Astellas Pharma US Inc$352
- Alimera Sciences, Inc.$228
- AbbVie$185
- Biogen$144
- plus $411 from 9 others
What the payments were for
- Food & beverage$2,468100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 5 | $578 |
| Genentech USA, Inc. | 16 | $570 |
| Astellas Pharma US Inc | 12 | $352 |
| Alimera Sciences, Inc. | 5 | $228 |
| AbbVie(2 entities) | 6 | $185 |
| Biogen | 6 | $144 |
| Genentech, Inc. | 1 | $123 |
| Mallinckrodt Hospital Products Inc. | 1 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Optos, Inc. | 2 | $37 |
| Novartis | 2 | $37 |
| Apellis Pharmaceuticals, Inc. | 1 | $35 |
| Ocular Therapeutix, Inc. | 1 | $30 |
| Amgen | 1 | $19 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURIFIED CORTROPHIN GEL$465
- VABYSMO$149
- Iluvien$147
- Lucentis$123
- Non-Covered Product$123
How this compares
$2,468 in reported general payments places this provider in the 35th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 71 | $3,327 |
| Difluprednate | 32 | $2,804 |
| MoxifloxacinMoxifloxacin Hcl | 36 | $611 |
| Latanoprost | 17 | $322 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Walnut Creek
- Roger GoldbergWalnut Creek$1.1M
- Caesar LuoWalnut Creek$294K
- Subhransu RayWalnut Creek$16K
- Dilsher DhootSanta Barbara$1.9M
- Ehsan RahimyStanford$1.5M
- Darius MoshfeghiPalo Alto$1.4M
- Nathan SteinleSanta Barbara$1.1M
- Baruch KuppermannIrvine$1M
- Carlos Medina MendezSacramento$548K
- Michael JavaheriBeverly Hills$540K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.